DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $845,779 | +8.9% | 94,395 | +36.7% | 0.00% | – |
| Q2 2023 | $776,712 | -72.0% | 69,041 | -71.3% | 0.00% | -100.0% |
| Q1 2023 | $2,775,099 | +77.7% | 240,894 | +78.7% | 0.00% | – |
| Q4 2022 | $1,562,077 | -10.7% | 134,778 | -2.1% | 0.00% | -100.0% |
| Q3 2022 | $1,749,000 | +2142.3% | 137,737 | +1114.0% | 0.00% | – |
| Q2 2022 | $78,000 | -30.4% | 11,346 | -3.0% | 0.00% | – |
| Q1 2022 | $112,000 | -17.6% | 11,698 | +2.6% | 0.00% | – |
| Q4 2021 | $136,000 | -27.3% | 11,406 | -1.2% | 0.00% | – |
| Q3 2021 | $187,000 | -10.5% | 11,541 | +15.9% | 0.00% | – |
| Q2 2021 | $209,000 | – | 9,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |